Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Apr 23 09:41AM ET
4.96
Dollar change
+0.21
Percentage change
4.42
%
Index- P/E- EPS (ttm)-0.25 Insider Own- Shs Outstand16.62M Perf Week-2.94%
Market Cap82.53M Forward P/E76.23 EPS next Y0.07 Insider Trans- Shs Float8.24M Perf Month-14.63%
Income-4.20M PEG- EPS next Q-0.02 Inst Own24.06% Short Float0.91% Perf Quarter-15.21%
Sales31.79M P/S2.60 EPS this Y84.12% Inst Trans- Short Ratio0.68 Perf Half Y43.35%
Book/sh2.50 P/B1.98 EPS next Y415.09% ROA-6.59% Short Interest0.07M Perf Year213.92%
Cash/sh2.78 P/C1.78 EPS next 5Y- ROE-9.65% 52W Range1.38 - 7.61 Perf YTD-23.46%
Dividend Est.- P/FCF- EPS past 5Y20.12% ROI-10.04% 52W High-34.87% Beta1.21
Dividend TTM- Quick Ratio5.30 Sales past 5Y15.88% Gross Margin73.86% 52W Low259.42% ATR (14)0.31
Dividend Ex-Date- Current Ratio5.68 EPS Y/Y TTM68.68% Oper. Margin-15.60% RSI (14)40.02 Volatility7.08% 5.80%
Employees106 Debt/Eq0.01 Sales Y/Y TTM16.96% Profit Margin-13.20% Recom1.00 Target Price10.85
Option/ShortNo / Yes LT Debt/Eq0.01 EPS Q/Q103.25% Payout- Rel Volume0.17 Prev Close4.75
Sales Surprise4.40% EPS Surprise100.00% Sales Q/Q49.66% EarningsMar 06 BMO Avg Volume110.62K Price4.96
SMA20-5.34% SMA50-14.79% SMA2003.80% Trades Volume1,408 Change4.42%
Date Action Analyst Rating Change Price Target Change
Nov-16-23Downgrade Raymond James Outperform → Mkt Perform
Mar-03-22Initiated Loop Capital Buy $15
Jul-19-21Initiated H.C. Wainwright Buy $17
Apr-20-21Initiated Northland Capital Outperform $15
May-13-19Initiated Raymond James Outperform $14
May-13-19Initiated Oppenheimer Outperform
May-13-19Initiated Ladenburg Thalmann Buy
May-13-19Initiated Cantor Fitzgerald Overweight $17
Apr-17-24 08:00AM
Apr-04-24 08:00AM
Mar-28-24 08:00AM
Mar-27-24 09:35AM
Mar-18-24 12:00PM
07:30AM Loading…
07:30AM
Mar-06-24 12:52PM
07:30AM
Mar-05-24 08:20AM
Feb-21-24 08:00AM
Feb-06-24 03:51PM
Jan-25-24 08:32AM
Jan-10-24 07:30AM
Jan-03-24 08:50AM
Dec-27-23 09:55AM
09:40AM Loading…
Dec-22-23 09:40AM
07:10AM
Dec-19-23 07:30AM
Dec-14-23 08:50AM
Dec-11-23 09:55AM
Dec-08-23 08:16AM
Dec-07-23 08:00AM
Nov-29-23 12:00PM
Nov-28-23 01:29PM
08:50AM
Nov-23-23 09:55AM
Nov-20-23 07:30AM
Nov-15-23 07:30AM
Nov-02-23 08:00AM
Nov-01-23 08:00AM
09:40AM Loading…
Oct-24-23 09:40AM
Oct-16-23 07:30AM
Oct-06-23 09:40AM
Sep-27-23 08:00AM
Sep-20-23 07:30AM
Sep-13-23 09:40AM
Sep-05-23 07:30AM
Aug-28-23 10:41AM
09:40AM
Aug-23-23 07:30AM
06:00AM
Aug-09-23 07:30AM
Aug-03-23 08:00AM
Jul-26-23 08:00AM
Jul-11-23 07:30AM
Jun-21-23 08:00AM
May-23-23 07:30AM
May-17-23 07:30AM
May-15-23 08:00AM
May-12-23 09:55AM
May-03-23 08:00AM
May-02-23 08:00AM
Mar-28-23 08:00AM
Mar-15-23 07:30AM
Mar-02-23 08:00AM
Mar-01-23 08:00AM
Feb-23-23 08:00AM
Feb-13-23 07:30AM
07:30AM
Feb-01-23 08:00AM
Jan-31-23 08:00AM
Jan-11-23 08:00AM
Jan-10-23 12:27PM
08:00AM
07:47AM
Dec-13-22 09:15AM
Nov-28-22 07:30AM
Nov-16-22 07:30AM
Nov-03-22 08:00AM
Nov-02-22 08:00AM
Nov-01-22 08:00AM
Oct-12-22 08:00AM
Oct-11-22 08:00AM
Sep-20-22 09:00AM
Sep-14-22 07:30AM
Aug-31-22 09:00AM
Aug-29-22 11:31AM
11:15AM
08:00AM
Aug-11-22 02:50PM
Aug-10-22 07:30AM
Jul-27-22 08:00AM
Jul-26-22 12:00PM
Jul-13-22 09:55AM
04:23AM
Jun-28-22 08:00AM
Jun-22-22 08:00AM
Jun-21-22 08:00AM
May-11-22 07:30AM
May-09-22 08:00AM
May-04-22 08:00AM
May-02-22 08:46AM
Apr-27-22 08:00AM
Mar-28-22 08:00AM
Mar-15-22 08:00AM
Mar-09-22 07:30AM
Mar-01-22 08:00AM
Feb-28-22 08:00AM
Feb-23-22 08:00AM
Feb-01-22 08:00AM
Brainsway Ltd. engages in the development and sale of non-invasive neurostimulation treatments using the proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) technology for the treatment of major depressive disorder (MDD) and obsessive-compulsive disorder (OCD). The Deep TMS uses magnetic pulses to stimulate neurons and consequently modulates the physiological activity of the brain. The company was founded by Avner Hagai, Yiftach Roth, Abraham Zangen, and David Zacut on November 7, 2006 and is headquartered in Jerusalem, Israel.